Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Beijing — China’s WuXi AppTec said on Sunday it has no affiliation with any governments or their military organisations, and it should not be listed as a “biotechnology company of concern” in a draft US bill.
The drug research and development group said in a filing to the Shanghai Stock Exchange that it has no human genomics business and does not collect human genome data in any of its existing businesses.
Shares of WuXi AppTec plunged 21.2% to their lowest since August 2019 on Friday as investors fears grew over the US bill.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
WuXi AppTec objects to listing on US bill
Beijing — China’s WuXi AppTec said on Sunday it has no affiliation with any governments or their military organisations, and it should not be listed as a “biotechnology company of concern” in a draft US bill.
The drug research and development group said in a filing to the Shanghai Stock Exchange that it has no human genomics business and does not collect human genome data in any of its existing businesses.
Shares of WuXi AppTec plunged 21.2% to their lowest since August 2019 on Friday as investors fears grew over the US bill.
Reuters
Bayer faces Australian test with judge to decide whether weedkiller caused cancer
US lobby groups pour cash into drug price blame game
WILMOT JAMES: Push to improve biosecurity in the age of genetic engineering
Activist investor Elliott has drugmaker BioMarin in its sights
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
Bayer faces Australian test with judge to decide whether weedkiller caused ...
US lobby groups pour cash into drug price blame game
WILMOT JAMES: Push to improve biosecurity in the age of genetic engineering
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.